1. Home
  2. TVA vs SLP Comparison

TVA vs SLP Comparison

Compare TVA & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVA
  • SLP
  • Stock Information
  • Founded
  • TVA 2024
  • SLP 1996
  • Country
  • TVA United States
  • SLP United States
  • Employees
  • TVA N/A
  • SLP N/A
  • Industry
  • TVA
  • SLP EDP Services
  • Sector
  • TVA
  • SLP Technology
  • Exchange
  • TVA Nasdaq
  • SLP Nasdaq
  • Market Cap
  • TVA 303.4M
  • SLP 282.4M
  • IPO Year
  • TVA 2025
  • SLP 1997
  • Fundamental
  • Price
  • TVA $10.12
  • SLP $13.84
  • Analyst Decision
  • TVA
  • SLP Buy
  • Analyst Count
  • TVA 0
  • SLP 7
  • Target Price
  • TVA N/A
  • SLP $29.50
  • AVG Volume (30 Days)
  • TVA 30.0
  • SLP 360.6K
  • Earning Date
  • TVA 01-01-0001
  • SLP 10-22-2025
  • Dividend Yield
  • TVA N/A
  • SLP N/A
  • EPS Growth
  • TVA N/A
  • SLP N/A
  • EPS
  • TVA N/A
  • SLP N/A
  • Revenue
  • TVA N/A
  • SLP $80,383,000.00
  • Revenue This Year
  • TVA N/A
  • SLP $12.75
  • Revenue Next Year
  • TVA N/A
  • SLP $3.06
  • P/E Ratio
  • TVA N/A
  • SLP N/A
  • Revenue Growth
  • TVA N/A
  • SLP 20.01
  • 52 Week Low
  • TVA $9.99
  • SLP $12.39
  • 52 Week High
  • TVA $10.34
  • SLP $37.67
  • Technical
  • Relative Strength Index (RSI)
  • TVA N/A
  • SLP 43.15
  • Support Level
  • TVA N/A
  • SLP $13.93
  • Resistance Level
  • TVA N/A
  • SLP $14.52
  • Average True Range (ATR)
  • TVA 0.00
  • SLP 0.50
  • MACD
  • TVA 0.00
  • SLP 0.10
  • Stochastic Oscillator
  • TVA 0.00
  • SLP 11.86

About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share

Texas Ventures Acquisition III Corp is a blank check company.

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Share on Social Networks: